サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血漿タンパク質治療薬の世界市場の分析 (2022年～2032年)：製品別・用途別の予測、地域別・主要国の分析、主要企業、新型コロナウイルス感染症 (COVID-19) からの回復シナリオ
市場調査レポート
商品コード
1088888

血漿タンパク質治療薬の世界市場の分析 (2022年～2032年)：製品別・用途別の予測、地域別・主要国の分析、主要企業、新型コロナウイルス感染症 (COVID-19) からの回復シナリオ

Plasma Protein Therapeutics Market Report 2022-2032: Forecasts by Product, by Application, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios
出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 225 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=198.76円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

血漿タンパク質治療薬の世界市場の分析 (2022年～2032年)：製品別・用途別の予測、地域別・主要国の分析、主要企業、新型コロナウイルス感染症 (COVID-19) からの回復シナリオ
出版日: 2022年06月09日
発行: Visiongain Reports Ltd.
ページ情報: 英文 225 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血漿タンパク質治療薬の市場規模は、2022年には280億米ドル以上に達する見通しです。また、2032年にかけて市場収益が大きく拡大すると見込まれています。

当レポートでは、世界の血漿タンパク質治療薬の市場について分析し、製品の概要や市場の基本構造・最新情勢、主な促進・抑制要因、市場規模の推定値・予測値 (2022年～2032年)、製品別・用途別および地域別・主要国の詳細動向、主要企業のプロファイル、COVID-19の影響と回復シナリオ、といった情報を取りまとめてお届けいたします。

目次

第1章 分析概要

第2章 エグゼクティブサマリー

第3章 世界の血漿タンパク質治療薬の市場力学

  • 血漿タンパク質治療薬市場へのCOVID-19の影響
  • 血漿タンパク質治療薬市場の現在の動向
  • 市場促進要因
  • 市場抑制要因
  • 世界市場の機会
  • ポーターのファイブフォース分析
  • SWOT分析

第4章 世界の血漿タンパク質治療薬市場の分析：製品別

  • セグメント別の概要
  • 免疫グロブリン
  • アルブミン
  • 凝固因子
  • C1-エステラーゼ阻害剤 (C1-INH)
  • 世界の市場規模の推定と予測：製品別
    • COVID-19以前の市場シナリオ
    • COVID-19以後の市場シナリオ (V字型/U字型/W字型/L字型の回復分析)

第5章 世界の血漿タンパク質治療薬市場の分析：用途別

  • セグメント別の概要
  • 血友病
  • 原発性免疫不全症 (PID)
  • 特発性血小板減少性紫斑病 (ITP)
  • 二次免疫不全
  • 遺伝性血管浮腫
  • 世界の市場規模の推定と予測：用途別

第6章 血漿タンパク質治療薬市場：地域別・主要国の予測 (2022年～2032年)

第7章 北米の血漿タンパク質治療薬市場

  • 地域別の概要
  • 血漿タンパク質治療薬市場の予測：国別 (2022年～2032年)
  • 血漿タンパク質治療薬市場の予測：製品別
  • 血漿タンパク質治療薬市場の予測：用途別
  • 米国
  • カナダ
  • COVID-19以後の回復シナリオ：国別

第8章 欧州の血漿タンパク質治療薬市場

  • 地域別の概要
  • 血漿タンパク質治療薬市場の予測：国別 (2022年～2032年)
  • 血漿タンパク質治療薬市場の予測：製品別
  • 血漿タンパク質治療薬市場の予測：用途別
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • 他の欧州諸国
  • COVID-19以後の回復シナリオ：国別

第9章 アジア太平洋の血漿タンパク質治療薬市場

  • 地域別の概要
  • 血漿タンパク質治療薬市場の予測：国別 (2022年～2032年)
  • 血漿タンパク質治療薬市場の予測：製品別
  • 血漿タンパク質治療薬市場の予測：用途別
  • 日本の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • 中国の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • インドの血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • オーストラリアの血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • 韓国の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • 他のアジア太平洋諸国の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • COVID-19以後の回復シナリオ：国別

第10章 ラテンアメリカの血漿タンパク質治療薬市場

  • 地域別の概要
  • 血漿タンパク質治療薬市場の予測：国別 (2022年～2032年)
  • 血漿タンパク質治療薬市場の予測：製品別
  • 血漿タンパク質治療薬市場の予測：用途別
  • ブラジルの血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • メキシコの血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • 他のラテンアメリカ諸国の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • COVID-19以後の回復シナリオ：国別

第11章 中東・アフリカの血漿タンパク質治療薬市場

  • 市場概要
  • 血漿タンパク質治療薬市場の予測：国別 (2022年～2032年)
  • 血漿タンパク質治療薬市場の予測：製品別
  • 血漿タンパク質治療薬市場の予測：用途別
  • 湾岸協力会議 (GCC) 諸国の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • 南アフリカの血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • 他の中東・アフリカ諸国の血漿タンパク質治療薬市場の予測 (2022年～3032年)
  • COVID-19以後の回復シナリオ：国別

第12章 企業プロファイル

  • ADMA Biologics、Inc.
    • 企業のスナップショット
    • 企業概要
    • 財務分析
    • 製品ベンチマーク
    • 昨今の動向
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings Inc.
  • CSL Behring
  • Grifols SA
  • Kedrion SpA
  • Octapharma AG
  • Takeda Pharmaceutical Company Ltd

第13章 結論と結論

図表

List of Tables

  • Table 1 Global Plasma Protein Therapeutics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
  • Table 2 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 3 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 4 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 5 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 6 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 7 Global Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 8 Global Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 9 Global Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 10 Global Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 11 Global Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 12 Global Plasma Protein Therapeutics Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 13 Global Plasma Protein Therapeutics Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 14 Global Plasma Protein Therapeutics Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 15 Global Plasma Protein Therapeutics Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 16 Global Plasma Protein Therapeutics Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 17 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 18 North America Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 19 North America Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 20 U.S. Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 21 Canada Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 22 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 23 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 24 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 25 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 26 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 27 Europe Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 28 Europe Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 29 Germany Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 30 UK Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 31 France Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 32 Italy Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 33 Spain Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 34 Rest of Europe Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 35 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 36 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 37 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 38 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 39 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 40 Asia Pacific Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 41 Asia Pacific Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 42 Japan Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 43 China Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 44 India Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 45 Australia Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 46 South Korea Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 47 Rest of Asia Pacific Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 48 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 49 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 50 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 51 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 52 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 53 Latin America Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 54 Latin America Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 55 Brazil Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 56 Mexico Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 57 Rest of Latin America Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 58 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 59 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 60 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 61 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 62 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 63 MEA Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 64 MEA Plasma Protein Therapeutics Market Forecast by Application, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 65 GCC Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 66 South Africa Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 67 Rest of MEA Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 68 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 69 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 70 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 71 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 72 ADMA Biologics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 73 ADMA Biologics Inc.: Product Benchmarking
  • Table 74 ADMA Biologics, Inc.: Recent Developments
  • Table 75 Bio Products Laboratory Ltd.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Bio Products Laboratory Ltd.: Product Benchmarking
  • Table 77 Bio Products Laboratory Ltd.: Recent Developments
  • Table 78 Biotest AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Biotest AG: Product Benchmarking
  • Table 80 Biotest AG: Recent Developments
  • Table 81 China Biologic Products Holdings Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 China Biologic Products Holdings Inc.: Product Benchmarking
  • Table 83 China Biologic Products Holdings Inc.: Recent Developments
  • Table 84 CSL Behring: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 CSL Behring: Product Benchmarking
  • Table 86 CSL Behring: Recent Developments
  • Table 87 Grifols SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Grifols SA: Product Benchmarking
  • Table 89 Grifols SA: Recent Developments
  • Table 90 Kedrion SpA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Kedrion SpA: Product Benchmarking
  • Table 92 Octapharma AG: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Octapharma AG: Product Benchmarking
  • Table 94 Octapharma AG: Recent Developments
  • Table 95 Takeda Pharmaceutical Company Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Takeda Pharmaceutical Company Ltd: Product Benchmarking
  • Table 97 Takeda Pharmaceutical Company Ltd: Recent Developments

List of Figures

  • Figure 1 Global Plasma Protein Therapeutics Market: Market Segmentation
  • Figure 2 Global Plasma Protein Therapeutics Market Trends
  • Figure 3 Global Plasma Protein Therapeutics Market: Porter's Five Forces
  • Figure 4 Global Plasma Protein Therapeutics Market: SWOT Analysis
  • Figure 5 Global Plasma Protein Therapeutics Market Share Forecast by Product: 2022, 2027, 2032 (%)
  • Figure 6 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR %)
  • Figure 7 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 8 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 9 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 10 Global Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 11 Global Plasma Protein Therapeutics Market Share Forecast by Applications: 2022, 2027, 2032 (%)
  • Figure 12 Global Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
  • Figure 13 Global Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 14 Global Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 15 Global Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 16 Global Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 17 Global Plasma Protein Therapeutics Market Forecast by Region 2022-2032 (US$ million)
  • Figure 18 Global Plasma Protein Therapeutics Market Share Forecast by Region 2022, 2027, 2032 (%)
  • Figure 19 Global Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 20 Global Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 21 Global Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 22 Global Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 23 North America Plasma Protein Therapeutics Market Forecast by Country 2022-2032 (US$ million)
  • Figure 24 North America Plasma Protein Therapeutics Market Share Forecast by Country 2022, 2027, 2032 (%)
  • Figure 25 North America Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 26 North America Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million)
  • Figure 27 U.S. Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 28 Canada Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 29 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 30 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 31 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 32 North America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 33 Europe Plasma Protein Therapeutics Market Forecast by Country 2022-2032 (US$ million)
  • Figure 34 Europe Plasma Protein Therapeutics Market Share Forecast by Country 2022, 2027, 2032 (%)
  • Figure 35 Europe Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR%)
  • Figure 36 Europe Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%)
  • Figure 37 Germany Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 38 UK Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 39 France Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 40 Italy Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 41 Spain Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 42 Rest of Europe Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 43 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 44 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 45 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 46 Europe Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 47 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country 2022-2032 (US$ million)
  • Figure 48 Asia Pacific Plasma Protein Therapeutics Market Share Forecast by Country 2022, 2027, 2032 (%)
  • Figure 49 Asia Pacific Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 50 Asia Pacific Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%)
  • Figure 51 Japan Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 52 China Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 53 India Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 54 Australia Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 55 South Korea Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 56 Rest of Asia Pacific Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 57 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 58 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 59 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 60 Asia Pacific Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 61 Latin America Plasma Protein Therapeutics Market Forecast by Country 2022-2032 (US$ million)
  • Figure 62 Latin America Plasma Protein Therapeutics Market Share Forecast by Country 2022, 2027, 2032 (%)
  • Figure 63 Latin America Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR%)
  • Figure 64 Latin America Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%)
  • Figure 65 Brazil Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 66 Mexico Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 67 Rest of Latin America Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 68 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 69 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 70 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 71 Latin America Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 72 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Country 2022-2032 (US$ million)
  • Figure 73 Middle East and Africa Plasma Protein Therapeutics Market Share Forecast by Country 2022, 2027, 2032 (%)
  • Figure 74 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Product, 2022-2032 (US$ million, AGR%)
  • Figure 75 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%)
  • Figure 76 GCC Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 77 South Africa Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 78 Rest of Middle East and Africa Plasma Protein Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 79 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "V" Shaped Recovery
  • Figure 80 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "U" Shaped Recovery
  • Figure 81 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "W" Shaped Recovery
  • Figure 82 MEA Plasma Protein Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %): "L" Shaped Recovery
  • Figure 83 ADMA Biologics, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 84 ADMA Biologics, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 85 ADMA Biologics, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 86 Biotest AG: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 87 CSL Behring: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 88 CSL Behring: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 89 CSL Behring: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 90 Grifols SA: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 91 Grifols SA: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 92 Grifols SA: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 93 Kedrion SpA: Net Revenue, 2018-2020 (US$ million, AGR%)
  • Figure 94 Kedrion SpA: R&D Expenses, 2018-2020 (US$ million, AGR%)
  • Figure 95 Kedrion SpA: Gross Profit, 2018-2020 (US$ million, AGR%)
  • Figure 96 Takeda Pharmaceutical Company Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 97 Takeda Pharmaceutical Company Ltd: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 98 Takeda Pharmaceutical Company Ltd: Gross Profit, 2015-2021 (US$ million, AGR%)

Companies Profiled in the Report:

  • ADMA Biologics Inc.
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings Inc.
  • CSL Behring
  • Grifols SA
  • Kedrion SpA
  • Octapharma USA Inc.
  • Takeda Pharmaceutical Company Ltd

List of Other Companies:

  • Allozyne
  • Alteogen
  • Alvogen
  • Amarey Novamedical
  • Amega Biotech
  • Apotex
  • Astellas Pharma
  • Avesthagen
  • Biocad
  • BioGenomics
  • Biolab
  • Bionovis
  • BioXpress Therapeutics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cambridge Antibody Technology
  • CCL Pharmaceuticals
  • CCM Duopharma
  • Celltrion
  • Centocor Ortho Biotech
  • Chong Kun Dang
  • Chugai
  • CinnaGen.
  • Coherus BioSciences
  • Compass Biotechnologies
  • Cristália
  • CT Arzneimittel
  • Cyplasin
  • Daiichi Sankyo
  • Dong-A Pharmaceutical
  • Dr. Reddy's Laboratories
  • Egis Pharmaceuticals
  • Eisai
  • Eli Lilly
  • Elpen Pharmaceutical
  • Emcure Pharmaceuticals
  • EMS
  • Epirus
  • Eurofarma
  • Express Scripts
  • FibroGen
  • Finox Biotech
  • Fuji Pharma
  • Gan & Lee
  • Genetech
  • Genexine
  • Gennova
  • GenSci
  • Genzyme
  • Geropharm
  • Gilead Sciences
  • GlaxoSmithKline
  • Hangzhou Jiuyuan Gene Engineering Co.
  • Hanmi Pharmaceutical
  • Hanwha Chemical
  • Haselmeier
  • Health Canada
  • Helius Biotech
  • Hexal
  • Hindustan Antibiotic
  • Hospira
  • Hualida Biotech
  • Hypermarcas
  • IGES Institute
  • Intas Biopharmaceuticals
  • inVentiv Health
  • JCR Pharmaceuticals
  • Kabi
  • Kemwell Biopharma
  • Kissea
  • Koçak Farma
  • Kwizda Pharma
  • Kyowa Hakko Kirin
  • Landsteiner Scientific
  • LG Life Sciences
  • Libbs
  • LKM SA
  • Lonza
  • Marvel Life Sciences
  • Minapharm
  • Mitsubishi Tanabe
  • Mochida Pharmaceutical
  • Momenta Pharmaceuticals
  • Mycenax Biotech
  • Mylan
  • Nichi-Iko
  • Nippion Kayaku
  • Novo Nordisk
  • Nuron Biotech
  • Pharmstandard
  • PRA International
  • Pro Generika
  • PROBIOMED
  • Qilu Pharmaceutical
  • Quintiles
  • Ranbaxy Laboratories
  • Ratiopharm
  • Regeneron Pharmaceuticals
  • Reliance Life Sciences (RLS)
  • Rentschler Biotechnologie
  • Sandoz
  • Sanofi
  • SciGen
  • Shandong Kexing Pharma
  • Shanghai Celgen Biopharmaceutical
  • Shanghai CP Guojian
  • Shanghai Fosun
  • Shantha Biotechnics
  • Shinogi
  • Sicor Biotech
  • Sothema Laboratories
  • Spectrum Pharmaceuticals
  • Stragen Pharma
  • Strides Arcolab
  • Syngene International
  • Synthon Biopharmaceuticals
  • Takeda
  • Tianjin Hualida Biotechnology
  • Tonghua Dongbao
  • TSH Biopharm Corp
  • União Química
  • USV Biologics
  • Virchow Biotech
  • Wanbang Biopharmaceuticals
  • Wockhardt
  • Xiamen Amoytop Biotech
  • Zenotech
  • Zuventus

List of Organizations:

  • Association of International Pharmaceutical Manufacturers
  • Chinese Pharmaceutical Association
  • European Medicines Agency
  • Federal Drugs Agency
  • IFPMA
  • Indian Drug Manufacturers' Association
  • International Federation of Pharmaceutical Manufacturers & Associations
  • International Pharmaceutical Federation
  • Jordanian Association of Pharmaceutical Manufacturers
  • Medicines and Healthcare Products Regulatory Agency
  • National Association of Pharmaceutical Manufacturers
  • Pharma & Biopharma Outsourcing Association (PBOA)
  • Pharmaceutical Group of the European Union
  • Pharmaceutical Manufacturers Association (PMA)
  • Pharmaceutical Society of Australia
  • Pharmaceutical Society of Ireland
  • Pharmaceutical Society Of New Zealand
  • Pharmaceutical Society of Northern Ireland
  • Royal Pharmaceutical Society
  • Singapore Association of Pharmaceutical Industries (SAPI)
  • Sri Lanka Pharmaceutical Manufacturers Association
  • The Association of the British Pharmaceutical Industry (ABPI)
  • The Australian Pharmaceutical Manufacturers Association
  • The European Federation of Pharmaceutical Industries and Associations
  • The European Personalised Medicine Association
  • The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  • The Korea Pharmaceutical and Bio-Pharma Manufacturers Association
目次
Product Code: PHA1003

Title:
Plasma Protein Therapeutics Market Report 2022-2032
Forecasts by Product (Immunoglobulins, Albumin, Coagulation Factors, C1-Esterase Inhibitor (C1-INH), Other), by Application (Hemophilia, Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura (ITP), Secondary Immunodeficiency, Hereditary Angioedema, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

Plasma Protein Therapeutics Market, 2022 to 2032- our new study reveals the latest industry trends, R&D progress, and predicted revenues

Increase of Blood Donations to Fuel Demand Across Low and Middle Income Countries

Due to the worldwide initiatives, a rise in voluntary, unpaid blood donations from low- and middle-income countries has been noted to fulfil the unmet need for red blood cell concentrates. In high-income nations, however, demand for red blood cells has been steadily declining, and with global economic advancements, this trend is anticipated to continue. As a result, it seems that the quantity of recovered plasma accessible for plasma fractionation is diminishing.

COVID-19 Disruption Hampering the Industry's Ability to Keep Pace with Growing Patient Pool

Plasma products are made possible by a meticulously designed, complicated system of willing donors, donation facilities, worldwide manufacturing networks, and pharmaceutical product distribution routes, which is generally reliable under normal conditions. The situation has become complicated with the outbreak of the coronavirus disease pandemic. The pandemic had a substantial influence on the well-developed and balanced system of plasma procurement beginning in early 2020, greatly impeding the industry's capacity to keep up with expanding patient demand for these life-changing medications.

Discover how to stay ahead

Our 220+ page report provides 180+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Plasma Protein Therapeutics Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter's Five Forces, SWOT Analysis, product profiles, and commercial developments.

Discover sales predictions for the world market and sub-markets

Product

  • Immunoglobulins
  • Albumin
  • Coagulation Factors
  • C1-Esterase Inhibitor (C1-INH)
  • Other Products

Applications

  • Hemophilia
  • Primary Immunodeficiency Disorder (PID)
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Secondary Immunodeficiency
  • Hereditary Angioedema
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Plasma Protein Therapeutics Market will surpass US$28 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Plasma Protein Therapeutics Market report helps you:

In summary, our 220+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Plasma Protein Therapeutics Market, with forecasts for 5 segmentations of the plasma protein therapeutics market, with forecasts for product and applications sub-segments each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2032 for five regional and 20 key national markets- See forecasts for the Plasma Protein Therapeutics Market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 9 of the companies involved in the Plasma Protein Therapeutics Market. Some of the companies profiled in this report include ADMA Biologics Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols SA, Kedrion SpA, Octapharma USA Inc., and Takeda Pharmaceutical Company Ltd, among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Plasma Protein Therapeutics Market and leading companies. You will find data, trends, and predictions.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Plasma Protein Therapeutics Market
  • 1.2 Plasma Protein Therapeutics Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered by this Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 COVID-19 Impact: Recovery Scenarios
    • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

  • 2.1 Segmental Analysis, 2022
  • 2.2 Regional Analysis, 2022

3 Global Plasma Protein Therapeutics Market Dynamics

  • 3.1 COVID-19 Impact on the Plasma Protein Therapeutics Market
  • 3.2 Current Trends in the Plasma Protein Therapeutics Market
  • 3.3 Market Driving Factors
    • 3.3.1 Increase Life Expectancy
    • 3.3.2 Provides Genomic Gains and Healthcare Savings
    • 3.3.3 Rising Demand for Immunoglobulins (IG)
    • 3.3.4 Growing Investments in Innovation
  • 3.4 Market Restraining Factors
    • 3.4.1 Stringent Regulations to Hamper Market Growth
    • 3.4.2 Demand for Plasma Therapies Outpacing Supply of Plasma
    • 3.4.3 Lack of Awareness
    • 3.4.4 COVID-19 Has Expanded the Gap Between Plasma Supply and Demand
  • 3.5 Opportunities in the Global Market
    • 3.5.1 Rising Incidence of Haemophilia
    • 3.5.2 Opportunities in Emerging Economies
  • 3.6 Porter's Five Forces Analysis
    • 3.6.1 Bargaining Power of Suppliers
    • 3.6.2 Bargaining Power of Buyers
    • 3.6.3 Threat of New Entrants
    • 3.6.4 Threat of Substitutes
    • 3.6.5 Competitive Rivalry
  • 3.7 SWOT Analysis
    • 3.7.1 Strengths
    • 3.7.2 Weaknesses
    • 3.7.3 Opportunities
    • 3.7.4 Threats

4 Global Plasma Protein Therapeutics Market Analysis by Product

  • 4.1 Segment Overview
  • 4.2 Immunoglobulins
  • 4.3 Albumin
  • 4.4 Coagulation Factors
  • 4.5 C1-Esterase Inhibitor (C1-INH)
  • 4.6 Global Market Size Estimation and Forecast by Product
    • 4.6.1 Pre-COVID-19 Market Scenario
    • 4.6.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

5 Global Plasma Protein Therapeutics Market Analysis by Applications

  • 5.1 Segment Overview
  • 5.2 Hemophilia
  • 5.3 Primary Immunodeficiency Disorder (PID)
  • 5.4 Idiopathic Thrombocytopenic Purpura (ITP)
  • 5.5 Secondary Immunodeficiency
  • 5.6 Hereditary Angioedema
  • 5.7 Global Market Size Estimation and Forecast by Applications
    • 5.7.1 Pre-COVID-19 Market Scenario
    • 5.7.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

6 Regional and Leading National Plasma Protein Therapeutics Market Forecasts 2022-2032

  • 6.1 Global Plasma Protein Therapeutics Market by Region Forecast 2022-2032
  • 6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 North America Plasma Protein Therapeutics Market

  • 7.1 Regional Overview
  • 7.2 North America Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 7.3 North America Plasma Protein Therapeutics Market Forecast by Product
  • 7.4 North America Plasma Protein Therapeutics Market Forecast by Applications
  • 7.5 U.S.
    • 7.5.1 U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology
    • 7.5.2 U.S. Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 7.6 Canada
    • 7.6.1 Introduction
    • 7.6.2 Canada Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 7.7 Post-COVID-19 Recovery Scenarios by Country

8 Europe Plasma Protein Therapeutics Market

  • 8.1 Regional Overview
  • 8.2 Europe Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 8.3 Europe Plasma Protein Therapeutics Market Forecast by Product
  • 8.4 Europe Plasma Protein Therapeutics Market Forecast by Applications
  • 8.5 Germany
    • 8.5.1 Plasma Donors Donate More Than Whole-Blood Donors
    • 8.5.2 Germany Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.6 UK
    • 8.6.1 UK Plasma Ban Lifted
    • 8.6.2 UK Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.7 France
    • 8.7.1 Versatile Policy to Process & Manufacture Therapeutic Plasma
    • 8.7.2 France Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.8 Italy
    • 8.8.1 Market Analysis
    • 8.8.2 Italy Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.9 Spain
    • 8.9.1 Spain Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.10 Rest of Europe
    • 8.10.1 Rest of Europe Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 8.11 Post-COVID-19 Recovery Scenarios by Country

9 Asia Pacific Plasma Protein Therapeutics Market

  • 9.1 Regional Overview
  • 9.2 Asia Pacific Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 9.3 Asia Pacific Plasma Protein Therapeutics Market Forecast by Product
  • 9.4 Asia Pacific Plasma Protein Therapeutics Market Forecast by Applications
  • 9.5 Japan Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.5.1 Market Analysis
    • 9.5.2 Japan Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.6 China Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.6.1 Market Analysis
    • 9.6.2 China Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.7 India Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.7.1 Market Analysis
    • 9.7.2 India Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.8 Australia Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.8.1 Australia Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.9 South Korea Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.9.1 Market Analysis
    • 9.9.2 South Korea Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.10 Rest of Asia Pacific Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 9.10.1 Rest of Asia Pacific Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 9.11 Post-COVID-19 Recovery Scenarios by Country

10 Latin America Plasma Protein Therapeutics Market

  • 10.1 Regional Overview
  • 10.2 Latin America Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 10.3 Latin America Plasma Protein Therapeutics Market Forecast by Product
  • 10.4 Latin America Plasma Protein Therapeutics Market Forecast by Applications
  • 10.5 Brazil Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 10.5.1 Market Analysis
    • 10.5.2 Brazil Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 10.6 Mexico Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 10.6.1 CSL Behring and Grifols to appeal US Border Patrol's Ban on Mexican Plasma Donations
    • 10.6.2 Mexico Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 10.7 Rest of Latin America Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 10.7.1 Rest of Latin America Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 10.8 Post-COVID-19 Recovery Scenarios by Country

11 Middle East and Africa Plasma Protein Therapeutics Market

  • 11.1 Market Overview
  • 11.2 Middle East and Africa Plasma Protein Therapeutics Market by Country, Forecast 2022-2032
  • 11.3 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Product
  • 11.4 Middle East and Africa Plasma Protein Therapeutics Market Forecast by Applications
  • 11.5 GCC Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 11.5.1 GCC Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 11.6 South Africa Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 11.6.1 South Africa Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 11.7 Rest of Middle East and Africa Plasma Protein Therapeutics Market Forecast, 2022-2032
    • 11.7.1 Rest of Middle East and Africa Plasma Protein Therapeutics Market Revenue, 2022-2032
  • 11.8 Post-COVID-19 Recovery Scenarios by Country

12 Company Profiles

  • 12.1 ADMA Biologics, Inc.
    • 12.1.1 Company Snapshot
    • 12.1.2 Company Overview
    • 12.1.3 Financial Analysis
    • 12.1.4 Product Benchmarking
    • 12.1.5 Recent Developments
  • 12.2 Bio Products Laboratory Ltd.
    • 12.2.1 Company Snapshot
    • 12.2.2 Company Overview
    • 12.2.3 Product Benchmarking
    • 12.2.4 Recent Developments
  • 12.3 Biotest AG
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Financial Analysis
    • 12.3.4 Product Benchmarking
    • 12.3.5 Recent Developments
  • 12.4 China Biologic Products Holdings Inc.
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Product Benchmarking
    • 12.4.4 Recent Developments
  • 12.5 CSL Behring
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Financial Analysis
    • 12.5.4 Product Benchmarking
    • 12.5.5 Recent Developments
  • 12.6 Grifols SA
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
    • 12.6.4 Product Benchmarking
    • 12.6.5 Recent Developments
  • 12.7 Kedrion SpA
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Financial Analysis
    • 12.7.4 Product Benchmarking
  • 12.8 Octapharma AG
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Product Benchmarking
    • 12.8.4 Recent Developments
  • 12.9 Takeda Pharmaceutical Company Ltd
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Financial Analysis
    • 12.9.4 Product Benchmarking
    • 12.9.5 Recent Developments

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks
  • 13.2 Recommendations